Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas.

Cancer Cell
Authors
Keywords
Abstract

We analyzed 921 adenocarcinomas of the esophagus, stomach, colon, and rectum to examine shared and distinguishing molecular characteristics of gastrointestinal tract adenocarcinomas (GIACs). Hypermutated tumors were distinct regardless of cancer type and comprised those enriched for insertions/deletions, representing microsatellite instability cases with epigenetic silencing of MLH1 in the context of CpG island methylator phenotype, plus tumors with elevated single-nucleotide variants associated with mutations in POLE. Tumors with chromosomal instability were diverse, with gastroesophageal adenocarcinomas harboring fragmented genomes associated with genomic doubling and distinct mutational signatures. We identified a group of tumors in the colon and rectum lacking hypermutation and aneuploidy termed genome stable and enriched in DNA hypermethylation and mutations in KRAS, SOX9, and PCBP1.

Year of Publication
2018
Journal
Cancer Cell
Volume
33
Issue
4
Pages
721-735.e8
Date Published
2018 04 09
ISSN
1878-3686
DOI
10.1016/j.ccell.2018.03.010
PubMed ID
29622466
PubMed Central ID
PMC5966039
Links
Grant list
U24 CA143882 / CA / NCI NIH HHS / United States
R01 AA023146 / AA / NIAAA NIH HHS / United States
U24 CA143866 / CA / NCI NIH HHS / United States
U54 HG003273 / HG / NHGRI NIH HHS / United States
T32 CA009172 / CA / NCI NIH HHS / United States
U24 CA143840 / CA / NCI NIH HHS / United States
U24 CA143843 / CA / NCI NIH HHS / United States
P01 CA098101 / CA / NCI NIH HHS / United States
U24 CA143848 / CA / NCI NIH HHS / United States
U24 CA210949 / CA / NCI NIH HHS / United States
R01 CA163722 / CA / NCI NIH HHS / United States
R50 CA221675 / CA / NCI NIH HHS / United States
U24 CA210990 / CA / NCI NIH HHS / United States
U54 HG003067 / HG / NHGRI NIH HHS / United States
U24 CA143835 / CA / NCI NIH HHS / United States
U24 CA210950 / CA / NCI NIH HHS / United States
U24 CA143799 / CA / NCI NIH HHS / United States
P30 CA008748 / CA / NCI NIH HHS / United States
U24 CA144025 / CA / NCI NIH HHS / United States
U24 CA143858 / CA / NCI NIH HHS / United States
R01 CA236591 / CA / NCI NIH HHS / United States
U24 CA210957 / CA / NCI NIH HHS / United States
I01 BX003732 / BX / BLRD VA / United States
U54 HG003079 / HG / NHGRI NIH HHS / United States
U24 CA210969 / CA / NCI NIH HHS / United States
U24 CA210999 / CA / NCI NIH HHS / United States
U24 CA143867 / CA / NCI NIH HHS / United States
U24 CA199461 / CA / NCI NIH HHS / United States